1319 related articles for article (PubMed ID: 11095430)
1. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
2. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
3. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands.
van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 1995 Dec; 80(12):3750-7. PubMed ID: 8530629
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2000 May; 52(5):625-32. PubMed ID: 10792343
[TBL] [Abstract][Full Text] [Related]
5. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects.
Roelfsema F; Pincus SM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Feb; 83(2):688-92. PubMed ID: 9467594
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin secretory dynamics in humans under low glucocorticoid feedback.
Veldhuis JD; Iranmanesh A; Naftolowitz D; Tatham N; Cassidy F; Carroll BJ
J Clin Endocrinol Metab; 2001 Nov; 86(11):5554-63. PubMed ID: 11701735
[TBL] [Abstract][Full Text] [Related]
7. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
van Aken MO; Pereira AM; Frölich M; Romijn JA; Pijl H; Veldhuis JD; Roelfsema F
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
[TBL] [Abstract][Full Text] [Related]
9. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
10. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease?
Buchfelder M; Fahlbusch R; Wentzlaff-Eggebert H; Brabant G; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1993 Sep; 77(3):720-4. PubMed ID: 8396575
[TBL] [Abstract][Full Text] [Related]
11. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
12. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
13. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
14. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
15. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
16. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
Maccario M; Veldhuis JD; Broglio F; Vito LD; Arvat E; Deghenghi R; Ghigo E
Eur J Endocrinol; 2002 Mar; 146(3):310-8. PubMed ID: 11888836
[TBL] [Abstract][Full Text] [Related]
17. Impact of age on cortisol secretory dynamics basally and as driven by nutrient-withdrawal stress.
Bergendahl M; Iranmanesh A; Mulligan T; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2203-14. PubMed ID: 10852453
[TBL] [Abstract][Full Text] [Related]
18. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts.
Charmandari E; Pincus SM; Matthews DR; Dennison E; Fall CH; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Jul; 86(7):3393-9. PubMed ID: 11443216
[TBL] [Abstract][Full Text] [Related]
19. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease.
van den Berg G; Pincus SM; Veldhuis JD; Frölich M; Roelfsema F
Eur J Endocrinol; 1997 Apr; 136(4):394-400. PubMed ID: 9150699
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
